

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-8 production (GO:0032717) | 7.91906110 |
| 2 | positive regulation of osteoblast proliferation (GO:0033690) | 7.47522595 |
| 3 | positive regulation of hair follicle development (GO:0051798) | 7.22668626 |
| 4 | positive regulation of hair cycle (GO:0042635) | 7.22668626 |
| 5 | angiogenesis involved in wound healing (GO:0060055) | 6.87433233 |
| 6 | regulation of Cdc42 GTPase activity (GO:0043088) | 6.59457458 |
| 7 | interferon-gamma production (GO:0032609) | 6.11176937 |
| 8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.07204257 |
| 9 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 6.03353528 |
| 10 | negative regulation of circadian rhythm (GO:0042754) | 6.00783771 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.99573234 |
| 12 | killing of cells of other organism (GO:0031640) | 5.67833283 |
| 13 | disruption of cells of other organism (GO:0044364) | 5.67833283 |
| 14 | protein K48-linked deubiquitination (GO:0071108) | 5.65004966 |
| 15 | sulfation (GO:0051923) | 5.53194688 |
| 16 | omega-hydroxylase P450 pathway (GO:0097267) | 5.50253676 |
| 17 | activated T cell proliferation (GO:0050798) | 5.49132612 |
| 18 | hematopoietic stem cell proliferation (GO:0071425) | 5.47858705 |
| 19 | vocalization behavior (GO:0071625) | 5.46998357 |
| 20 | protein K63-linked deubiquitination (GO:0070536) | 5.45372178 |
| 21 | lymphangiogenesis (GO:0001946) | 5.33369447 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 5.20640207 |
| 23 | glycoprotein catabolic process (GO:0006516) | 5.18389506 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 5.14516261 |
| 25 | thyroid hormone metabolic process (GO:0042403) | 5.04829223 |
| 26 | carnitine transmembrane transport (GO:1902603) | 5.01810135 |
| 27 | homocysteine metabolic process (GO:0050667) | 5.00817580 |
| 28 | flavonoid metabolic process (GO:0009812) | 4.90144267 |
| 29 | transmission of nerve impulse (GO:0019226) | 4.84688221 |
| 30 | synaptic vesicle maturation (GO:0016188) | 4.79657058 |
| 31 | defense response to fungus (GO:0050832) | 4.79568534 |
| 32 | proline transport (GO:0015824) | 4.77804422 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.77182238 |
| 34 | amino-acid betaine transport (GO:0015838) | 4.75060358 |
| 35 | carnitine transport (GO:0015879) | 4.75060358 |
| 36 | lipid translocation (GO:0034204) | 4.73414431 |
| 37 | phospholipid translocation (GO:0045332) | 4.73414431 |
| 38 | regulation of hair follicle development (GO:0051797) | 4.70457047 |
| 39 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.66602853 |
| 40 | behavioral fear response (GO:0001662) | 4.66510297 |
| 41 | behavioral defense response (GO:0002209) | 4.66510297 |
| 42 | neuron cell-cell adhesion (GO:0007158) | 4.63448119 |
| 43 | protein localization to synapse (GO:0035418) | 4.61879477 |
| 44 | mucosal immune response (GO:0002385) | 4.60904059 |
| 45 | cysteine metabolic process (GO:0006534) | 4.55107580 |
| 46 | filopodium assembly (GO:0046847) | 4.53872797 |
| 47 | glycerophospholipid catabolic process (GO:0046475) | 4.51160324 |
| 48 | carnitine metabolic process (GO:0009437) | 4.47588648 |
| 49 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.42705844 |
| 50 | neuron recognition (GO:0008038) | 4.38983442 |
| 51 | cerebellar Purkinje cell layer development (GO:0021680) | 4.37019740 |
| 52 | granulocyte differentiation (GO:0030851) | 4.36820073 |
| 53 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.33205683 |
| 54 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.30674140 |
| 55 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.25845231 |
| 56 | organ or tissue specific immune response (GO:0002251) | 4.21266688 |
| 57 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.17794922 |
| 58 | gonadal mesoderm development (GO:0007506) | 4.12551845 |
| 59 | fear response (GO:0042596) | 4.12152898 |
| 60 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.11490486 |
| 61 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.10477920 |
| 62 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.10477920 |
| 63 | cellular potassium ion homeostasis (GO:0030007) | 4.03777164 |
| 64 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.03109211 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.99900746 |
| 66 | organic cation transport (GO:0015695) | 3.99822937 |
| 67 | righting reflex (GO:0060013) | 3.95836124 |
| 68 | cell communication by electrical coupling (GO:0010644) | 3.94729477 |
| 69 | exploration behavior (GO:0035640) | 3.87350490 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 3.87010367 |
| 71 | negative regulation of hormone metabolic process (GO:0032351) | 3.86168910 |
| 72 | long-term memory (GO:0007616) | 3.82372709 |
| 73 | negative regulation of metanephros development (GO:0072217) | 3.81020786 |
| 74 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.79277219 |
| 75 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.77248457 |
| 76 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.72901143 |
| 77 | synaptic vesicle exocytosis (GO:0016079) | 3.71562631 |
| 78 | positive regulation of synapse maturation (GO:0090129) | 3.70648388 |
| 79 | axonal fasciculation (GO:0007413) | 3.70258820 |
| 80 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.67709104 |
| 81 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.65835359 |
| 82 | circadian sleep/wake cycle process (GO:0022410) | 3.64558439 |
| 83 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.62204333 |
| 84 | response to histamine (GO:0034776) | 3.61616866 |
| 85 | paraxial mesoderm development (GO:0048339) | 3.60236472 |
| 86 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.59645176 |
| 87 | quaternary ammonium group transport (GO:0015697) | 3.58711510 |
| 88 | regulation of sarcomere organization (GO:0060297) | 3.58309391 |
| 89 | neuronal action potential propagation (GO:0019227) | 3.58297599 |
| 90 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.58258263 |
| 91 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.58204828 |
| 92 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.52515362 |
| 93 | gamma-aminobutyric acid transport (GO:0015812) | 3.52291952 |
| 94 | membrane depolarization during action potential (GO:0086010) | 3.51847333 |
| 95 | reflex (GO:0060004) | 3.51433599 |
| 96 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.49043128 |
| 97 | regulation of hair cycle (GO:0042634) | 3.48040299 |
| 98 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.47232413 |
| 99 | postsynaptic membrane organization (GO:0001941) | 3.47075930 |
| 100 | amino-acid betaine metabolic process (GO:0006577) | 3.46333997 |
| 101 | central nervous system myelination (GO:0022010) | 3.46224586 |
| 102 | axon ensheathment in central nervous system (GO:0032291) | 3.46224586 |
| 103 | cell killing (GO:0001906) | 3.45175266 |
| 104 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.44246946 |
| 105 | vesicle transport along microtubule (GO:0047496) | 3.43497633 |
| 106 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.43421866 |
| 107 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.43167581 |
| 108 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.42957179 |
| 109 | indole-containing compound catabolic process (GO:0042436) | 3.40881825 |
| 110 | indolalkylamine catabolic process (GO:0046218) | 3.40881825 |
| 111 | tryptophan catabolic process (GO:0006569) | 3.40881825 |
| 112 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.40793511 |
| 113 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.39258620 |
| 114 | angiotensin maturation (GO:0002003) | 3.38699173 |
| 115 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 3.38682669 |
| 116 | regulation of synaptic plasticity (GO:0048167) | 3.38556867 |
| 117 | positive regulation of catecholamine secretion (GO:0033605) | 3.33836278 |
| 118 | locomotory exploration behavior (GO:0035641) | 3.33795265 |
| 119 | sex differentiation (GO:0007548) | 3.31641232 |
| 120 | androgen biosynthetic process (GO:0006702) | 3.31059233 |
| 121 | regulation of dopamine metabolic process (GO:0042053) | 3.31008392 |
| 122 | regulation of catecholamine metabolic process (GO:0042069) | 3.31008392 |
| 123 | regulation of postsynaptic membrane potential (GO:0060078) | 3.30952502 |
| 124 | positive regulation of epidermis development (GO:0045684) | 3.30527510 |
| 125 | regulation of membrane lipid distribution (GO:0097035) | 3.28752017 |
| 126 | presynaptic membrane assembly (GO:0097105) | 3.28236423 |
| 127 | glutamate secretion (GO:0014047) | 3.28199131 |
| 128 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.28166763 |
| 129 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.24553468 |
| 130 | response to fungus (GO:0009620) | 3.24279219 |
| 131 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24181342 |
| 132 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24150192 |
| 133 | long-term synaptic potentiation (GO:0060291) | 3.23670247 |
| 134 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.22816900 |
| 135 | cellular sodium ion homeostasis (GO:0006883) | 3.21987085 |
| 136 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.21075369 |
| 137 | membrane depolarization (GO:0051899) | 3.16380869 |
| 138 | startle response (GO:0001964) | 3.14590918 |
| 139 | membrane hyperpolarization (GO:0060081) | 3.11727638 |
| 140 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.11129150 |
| 141 | neurotransmitter secretion (GO:0007269) | 3.10559898 |
| 142 | glycosphingolipid biosynthetic process (GO:0006688) | 3.10290396 |
| 143 | digestion (GO:0007586) | 3.10243587 |
| 144 | presynaptic membrane organization (GO:0097090) | 3.09268302 |
| 145 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.09201808 |
| 146 | synaptic vesicle endocytosis (GO:0048488) | 3.08917189 |
| 147 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.07853032 |
| 148 | multicellular organismal signaling (GO:0035637) | 3.07474454 |
| 149 | neuronal ion channel clustering (GO:0045161) | 3.06134030 |
| 150 | rRNA catabolic process (GO:0016075) | 3.05394867 |
| 151 | striated muscle atrophy (GO:0014891) | 3.02764716 |
| 152 | neuromuscular synaptic transmission (GO:0007274) | 3.01448516 |
| 153 | regulation of dopamine secretion (GO:0014059) | 3.01127756 |
| 154 | striatum development (GO:0021756) | 3.00203634 |
| 155 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.00091684 |
| 156 | * synaptic transmission (GO:0007268) | 2.98621373 |
| 157 | learning (GO:0007612) | 2.97408577 |
| 158 | establishment of protein localization to Golgi (GO:0072600) | 2.97226441 |
| 159 | regulation of osteoblast proliferation (GO:0033688) | 2.96702006 |
| 160 | adult walking behavior (GO:0007628) | 2.96544559 |
| 161 | protein sumoylation (GO:0016925) | 2.96410557 |
| 162 | sodium ion export (GO:0071436) | 2.95859243 |
| 163 | endothelial cell proliferation (GO:0001935) | 2.94676569 |
| 164 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.94658439 |
| 165 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.94126173 |
| 166 | dendrite morphogenesis (GO:0048813) | 2.93397017 |
| 167 | layer formation in cerebral cortex (GO:0021819) | 2.92571219 |
| 168 | behavioral response to nicotine (GO:0035095) | 2.92076496 |
| 169 | regulation of synaptic vesicle transport (GO:1902803) | 2.91991977 |
| 170 | cellular ketone body metabolic process (GO:0046950) | 2.91531904 |
| 171 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.91405116 |
| 172 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.89025832 |
| 173 | negative regulation of mast cell activation (GO:0033004) | 2.88674031 |
| 174 | skeletal muscle adaptation (GO:0043501) | 2.88672739 |
| 175 | organelle transport along microtubule (GO:0072384) | 2.87108079 |
| 176 | innervation (GO:0060384) | 2.86910104 |
| 177 | regulation of female receptivity (GO:0045924) | 2.86565526 |
| 178 | regulation of dendritic spine development (GO:0060998) | 2.86442238 |
| 179 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.85590584 |
| 180 | serotonin metabolic process (GO:0042428) | 2.84158475 |
| 181 | neurotransmitter transport (GO:0006836) | 2.84037142 |
| 182 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.83252205 |
| 183 | skin development (GO:0043588) | 2.82826812 |
| 184 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.82776017 |
| 185 | positive regulation of vasculogenesis (GO:2001214) | 2.82676650 |
| 186 | cell migration in hindbrain (GO:0021535) | 2.82462156 |
| 187 | regulation of synapse structural plasticity (GO:0051823) | 2.81847535 |
| 188 | regulation of synaptic transmission (GO:0050804) | 2.81774598 |
| 189 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.79455665 |
| 190 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.79455665 |
| 191 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.79455665 |
| 192 | regulation of guanylate cyclase activity (GO:0031282) | 2.78894889 |
| 193 | sex determination (GO:0007530) | 2.76037137 |
| 194 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.74400974 |
| 195 | phosphatidic acid biosynthetic process (GO:0006654) | 2.72620577 |
| 196 | phosphatidic acid metabolic process (GO:0046473) | 2.72620577 |
| 197 | protein K11-linked deubiquitination (GO:0035871) | 13.8880261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 9.51502044 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.74384260 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.71075783 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.28444282 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13595319 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00127533 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93647668 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.90150587 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.80550164 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.79971285 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.79654332 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.77194363 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.77194363 |
| 14 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.64252335 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58876203 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46794545 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45087840 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36008551 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.35206209 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31415703 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30975492 |
| 22 | TP53_16413492_ChIP-PET_HCT116_Human | 2.28944769 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.26529166 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.14554203 |
| 25 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11520494 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08591689 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.07032215 |
| 28 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.06609983 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04651833 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03798033 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01621093 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.96489718 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94345050 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90098640 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.81324858 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.79775809 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.78518569 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74471196 |
| 39 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.69252240 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.65826391 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65711434 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.65554339 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64576374 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.63590678 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60980211 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.58001613 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57714983 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57695934 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57041685 |
| 50 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.54405943 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54398176 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54219256 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53443157 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52658205 |
| 55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52329649 |
| 56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.52303201 |
| 57 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.50875271 |
| 58 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50688099 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.48129937 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47413975 |
| 61 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43712020 |
| 62 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.43004702 |
| 63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.42935432 |
| 64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42788907 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.42074567 |
| 66 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40403992 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38329653 |
| 68 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.37896264 |
| 69 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.37070459 |
| 70 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.36123183 |
| 71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.35616468 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33930186 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32669468 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31976683 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31238520 |
| 76 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.30198320 |
| 77 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.27041120 |
| 78 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26343002 |
| 79 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25760673 |
| 80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24254378 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23298488 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22576396 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.21253625 |
| 84 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 1.19910847 |
| 85 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18266302 |
| 86 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17908193 |
| 87 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17336010 |
| 88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16470696 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16268754 |
| 90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.15860577 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15860577 |
| 92 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15763863 |
| 93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13244613 |
| 94 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13158204 |
| 95 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12500697 |
| 96 | JUN_21703547_ChIP-Seq_K562_Human | 1.10949291 |
| 97 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10912879 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10832922 |
| 99 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09355470 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07529970 |
| 101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07489816 |
| 102 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07008269 |
| 103 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05209622 |
| 104 | TBL1_22424771_ChIP-Seq_293T_Human | 1.04632682 |
| 105 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03872107 |
| 106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02861537 |
| 107 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.02837225 |
| 108 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.02626109 |
| 109 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02304127 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01861008 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01728051 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01389465 |
| 113 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.00348739 |
| 114 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.00348739 |
| 115 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.00348739 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99997740 |
| 117 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.98280479 |
| 118 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.97963777 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97053035 |
| 120 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96607854 |
| 121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96323036 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96013857 |
| 123 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.95751204 |
| 124 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.95308910 |
| 125 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.95308910 |
| 126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94951737 |
| 127 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93861524 |
| 128 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93805424 |
| 129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93771770 |
| 130 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.93204535 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92883705 |
| 132 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.92509754 |
| 133 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91877152 |
| 134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91568318 |
| 135 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90853623 |
| 136 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90387411 |
| 137 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90385325 |
| 138 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90142352 |
| 139 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90107930 |
| 140 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89880697 |
| 141 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88868560 |
| 142 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88349856 |
| 143 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.88077021 |
| 144 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88005648 |
| 145 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87915804 |
| 146 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.87758587 |
| 147 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87690943 |
| 148 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.87131691 |
| 149 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86887107 |
| 150 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86637758 |
| 151 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.86446062 |
| 152 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86159061 |
| 153 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85502758 |
| 154 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85434085 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85152631 |
| 156 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84799004 |
| 157 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84268551 |
| 158 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83303140 |
| 159 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83086854 |
| 160 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82944057 |
| 161 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81780498 |
| 162 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80740062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.19176949 |
| 2 | MP0003880_abnormal_central_pattern | 5.71483287 |
| 3 | MP0005670_abnormal_white_adipose | 5.13439255 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.42014121 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 4.28708914 |
| 6 | MP0005310_abnormal_salivary_gland | 4.26522950 |
| 7 | MP0005360_urolithiasis | 4.10901003 |
| 8 | MP0002822_catalepsy | 3.99675544 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.77604975 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 3.71877594 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 3.71265003 |
| 12 | MP0002735_abnormal_chemical_nociception | 3.51395489 |
| 13 | MP0004270_analgesia | 3.49703942 |
| 14 | MP0002736_abnormal_nociception_after | 3.49466775 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 3.43529563 |
| 16 | * MP0009745_abnormal_behavioral_response | 3.31200146 |
| 17 | MP0001501_abnormal_sleep_pattern | 3.30704105 |
| 18 | * MP0002063_abnormal_learning/memory/cond | 3.01933281 |
| 19 | MP0001984_abnormal_olfaction | 2.92307498 |
| 20 | * MP0002572_abnormal_emotion/affect_behav | 2.68104857 |
| 21 | * MP0002064_seizures | 2.61757915 |
| 22 | MP0002272_abnormal_nervous_system | 2.60578885 |
| 23 | MP0003787_abnormal_imprinting | 2.55726748 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 2.54877589 |
| 25 | MP0004858_abnormal_nervous_system | 2.54015874 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.53745973 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.45483028 |
| 28 | MP0002733_abnormal_thermal_nociception | 2.38447305 |
| 29 | MP0006276_abnormal_autonomic_nervous | 2.27375346 |
| 30 | MP0001486_abnormal_startle_reflex | 2.17386748 |
| 31 | MP0001970_abnormal_pain_threshold | 2.12323938 |
| 32 | MP0005423_abnormal_somatic_nervous | 2.11116480 |
| 33 | MP0005365_abnormal_bile_salt | 2.08117375 |
| 34 | MP0000230_abnormal_systemic_arterial | 1.91833250 |
| 35 | MP0003329_amyloid_beta_deposits | 1.88461256 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.81200301 |
| 37 | MP0009046_muscle_twitch | 1.78981893 |
| 38 | MP0003252_abnormal_bile_duct | 1.78279647 |
| 39 | MP0006292_abnormal_olfactory_placode | 1.78248965 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.77473312 |
| 41 | MP0001873_stomach_inflammation | 1.72568512 |
| 42 | MP0002184_abnormal_innervation | 1.71682569 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.64960601 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.61171819 |
| 45 | MP0001919_abnormal_reproductive_system | 1.59998515 |
| 46 | MP0001529_abnormal_vocalization | 1.51564221 |
| 47 | MP0006082_CNS_inflammation | 1.49628204 |
| 48 | MP0010386_abnormal_urinary_bladder | 1.49625872 |
| 49 | MP0003122_maternal_imprinting | 1.46017798 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.43209644 |
| 51 | MP0001879_abnormal_lymphatic_vessel | 1.42806612 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.38938492 |
| 53 | MP0001905_abnormal_dopamine_level | 1.38076739 |
| 54 | MP0000778_abnormal_nervous_system | 1.35494239 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.33867478 |
| 56 | MP0005389_reproductive_system_phenotype | 1.32534669 |
| 57 | MP0000955_abnormal_spinal_cord | 1.31667618 |
| 58 | MP0001764_abnormal_homeostasis | 1.29628707 |
| 59 | MP0001188_hyperpigmentation | 1.28872045 |
| 60 | MP0005332_abnormal_amino_acid | 1.27024250 |
| 61 | MP0003123_paternal_imprinting | 1.24655886 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.23943561 |
| 63 | MP0004147_increased_porphyrin_level | 1.22280849 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.20511670 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 1.20046153 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 1.17618189 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 1.17184286 |
| 68 | MP0005187_abnormal_penis_morphology | 1.16661514 |
| 69 | MP0000613_abnormal_salivary_gland | 1.16274606 |
| 70 | MP0002006_tumorigenesis | 1.15652344 |
| 71 | MP0002066_abnormal_motor_capabilities/c | 1.15536400 |
| 72 | MP0003879_abnormal_hair_cell | 1.14827039 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.14675652 |
| 74 | MP0003121_genomic_imprinting | 1.11802014 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.11655361 |
| 76 | MP0004142_abnormal_muscle_tone | 1.11082063 |
| 77 | MP0004085_abnormal_heartbeat | 1.10787010 |
| 78 | MP0003638_abnormal_response/metabolism_ | 1.07176000 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 1.06195253 |
| 80 | MP0003878_abnormal_ear_physiology | 1.06195253 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 1.05430556 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 1.04421185 |
| 83 | MP0003718_maternal_effect | 1.02814174 |
| 84 | MP0003195_calcinosis | 1.01108122 |
| 85 | MP0004215_abnormal_myocardial_fiber | 1.00877495 |
| 86 | MP0002127_abnormal_cardiovascular_syste | 0.99932985 |
| 87 | MP0003724_increased_susceptibility_to | 0.99347179 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.98381028 |
| 89 | MP0004924_abnormal_behavior | 0.98238151 |
| 90 | MP0005386_behavior/neurological_phenoty | 0.98238151 |
| 91 | MP0002971_abnormal_brown_adipose | 0.95290175 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.94990927 |
| 93 | MP0005646_abnormal_pituitary_gland | 0.92618632 |
| 94 | MP0008872_abnormal_physiological_respon | 0.91880193 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.91843167 |
| 96 | MP0003938_abnormal_ear_development | 0.90410503 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.88778716 |
| 98 | MP0008874_decreased_physiological_sensi | 0.88490659 |
| 99 | MP0000604_amyloidosis | 0.86237299 |
| 100 | MP0002928_abnormal_bile_duct | 0.85831244 |
| 101 | MP0004885_abnormal_endolymph | 0.85540770 |
| 102 | MP0008569_lethality_at_weaning | 0.84728826 |
| 103 | MP0002837_dystrophic_cardiac_calcinosis | 0.83864613 |
| 104 | MP0005083_abnormal_biliary_tract | 0.82736855 |
| 105 | MP0003633_abnormal_nervous_system | 0.80431435 |
| 106 | MP0001346_abnormal_lacrimal_gland | 0.80394786 |
| 107 | MP0001664_abnormal_digestion | 0.80126380 |
| 108 | MP0005394_taste/olfaction_phenotype | 0.79577201 |
| 109 | MP0005499_abnormal_olfactory_system | 0.79577201 |
| 110 | MP0002152_abnormal_brain_morphology | 0.78742297 |
| 111 | MP0001963_abnormal_hearing_physiology | 0.77552941 |
| 112 | MP0001177_atelectasis | 0.77037591 |
| 113 | * MP0002069_abnormal_eating/drinking_beha | 0.75884190 |
| 114 | MP0003646_muscle_fatigue | 0.75164824 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.74230101 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.74059211 |
| 117 | MP0000383_abnormal_hair_follicle | 0.74022870 |
| 118 | MP0002751_abnormal_autonomic_nervous | 0.73689628 |
| 119 | MP0001663_abnormal_digestive_system | 0.73678620 |
| 120 | MP0002229_neurodegeneration | 0.73584411 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.73307388 |
| 122 | MP0002752_abnormal_somatic_nervous | 0.73020600 |
| 123 | MP0002269_muscular_atrophy | 0.70263485 |
| 124 | MP0003631_nervous_system_phenotype | 0.69810873 |
| 125 | MP0002254_reproductive_system_inflammat | 0.68347527 |
| 126 | MP0002638_abnormal_pupillary_reflex | 0.68271504 |
| 127 | MP0004043_abnormal_pH_regulation | 0.68007982 |
| 128 | MP0004484_altered_response_of | 0.67238124 |
| 129 | MP0003315_abnormal_perineum_morphology | 0.66483701 |
| 130 | MP0005409_darkened_coat_color | 0.66429001 |
| 131 | MP0003632_abnormal_nervous_system | 0.66254344 |
| 132 | MP0005410_abnormal_fertilization | 0.66106087 |
| 133 | MP0005647_abnormal_sex_gland | 0.66092636 |
| 134 | MP0010678_abnormal_skin_adnexa | 0.64360173 |
| 135 | MP0005551_abnormal_eye_electrophysiolog | 0.63618066 |
| 136 | MP0001756_abnormal_urination | 0.63079517 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.62492345 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.62110306 |
| 139 | MP0005174_abnormal_tail_pigmentation | 0.60325962 |
| 140 | MP0005666_abnormal_adipose_tissue | 0.58321757 |
| 141 | MP0002136_abnormal_kidney_physiology | 0.56453964 |
| 142 | MP0001348_abnormal_lacrimal_gland | 0.56221493 |
| 143 | MP0000749_muscle_degeneration | 0.56079878 |
| 144 | MP0000678_abnormal_parathyroid_gland | 0.55764151 |
| 145 | MP0003861_abnormal_nervous_system | 0.55563368 |
| 146 | MP0002090_abnormal_vision | 0.54818268 |
| 147 | MP0001986_abnormal_taste_sensitivity | 0.54245954 |
| 148 | MP0000026_abnormal_inner_ear | 0.54215123 |
| 149 | MP0000427_abnormal_hair_cycle | 0.52944711 |
| 150 | MP0000249_abnormal_blood_vessel | 0.52792039 |
| 151 | MP0003011_delayed_dark_adaptation | 0.52641105 |
| 152 | MP0005595_abnormal_vascular_smooth | 0.52050587 |
| 153 | MP0003936_abnormal_reproductive_system | 0.51731774 |
| 154 | MP0003953_abnormal_hormone_level | 0.51116423 |
| 155 | MP0004084_abnormal_cardiac_muscle | 0.50446949 |
| 156 | MP0000538_abnormal_urinary_bladder | 0.50250825 |
| 157 | MP0000751_myopathy | 0.50249477 |
| 158 | MP0002653_abnormal_ependyma_morphology | 0.50235826 |
| 159 | MP0003075_altered_response_to | 0.49736536 |
| 160 | MP0005448_abnormal_energy_balance | 0.49371980 |
| 161 | MP0005075_abnormal_melanosome_morpholog | 0.49304358 |
| 162 | MP0010234_abnormal_vibrissa_follicle | 0.48568101 |
| 163 | MP0005376_homeostasis/metabolism_phenot | 0.48343817 |
| 164 | MP0001485_abnormal_pinna_reflex | 0.48146128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.03605429 |
| 2 | Myokymia (HP:0002411) | 7.71101958 |
| 3 | Congenital sensorineural hearing impairment (HP:0008527) | 7.46693364 |
| 4 | Febrile seizures (HP:0002373) | 6.41645593 |
| 5 | Focal seizures (HP:0007359) | 5.62215979 |
| 6 | Lower limb hyperreflexia (HP:0002395) | 5.38616932 |
| 7 | Bilateral sensorineural hearing impairment (HP:0008619) | 5.24100452 |
| 8 | Abnormality of the lower motor neuron (HP:0002366) | 5.17499415 |
| 9 | Optic neuritis (HP:0100653) | 4.91921495 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.91921495 |
| 11 | Atonic seizures (HP:0010819) | 4.82686989 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.80748176 |
| 13 | Orchitis (HP:0100796) | 4.49412550 |
| 14 | Epileptic encephalopathy (HP:0200134) | 4.45886795 |
| 15 | Hyperventilation (HP:0002883) | 4.32515832 |
| 16 | Keratoconjunctivitis (HP:0001096) | 4.29989525 |
| 17 | Dialeptic seizures (HP:0011146) | 4.24293945 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 4.23895674 |
| 19 | Abnormal pancreas size (HP:0012094) | 4.10309583 |
| 20 | Poikiloderma (HP:0001029) | 4.08342706 |
| 21 | Hydroxyprolinuria (HP:0003080) | 3.97744303 |
| 22 | Abnormality of proline metabolism (HP:0010907) | 3.97744303 |
| 23 | Hyperglycinuria (HP:0003108) | 3.89881399 |
| 24 | Visual hallucinations (HP:0002367) | 3.87163228 |
| 25 | Absence seizures (HP:0002121) | 3.76740024 |
| 26 | Attenuation of retinal blood vessels (HP:0007843) | 3.69044058 |
| 27 | Ileus (HP:0002595) | 3.65649821 |
| 28 | Myositis (HP:0100614) | 3.61328290 |
| 29 | Abnormality of the pericardium (HP:0001697) | 3.54534967 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 3.48500962 |
| 31 | Amblyopia (HP:0000646) | 3.48127147 |
| 32 | Drooling (HP:0002307) | 3.45548167 |
| 33 | Excessive salivation (HP:0003781) | 3.45548167 |
| 34 | Hypoplasia of the uterus (HP:0000013) | 3.45520639 |
| 35 | Xanthomatosis (HP:0000991) | 3.44564061 |
| 36 | Abolished electroretinogram (ERG) (HP:0000550) | 3.38776186 |
| 37 | Gout (HP:0001997) | 3.38163988 |
| 38 | Congenital stationary night blindness (HP:0007642) | 3.29302512 |
| 39 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.28758202 |
| 40 | Enlarged penis (HP:0000040) | 3.21489963 |
| 41 | Spastic tetraparesis (HP:0001285) | 3.18925184 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 3.15504754 |
| 43 | Hemiparesis (HP:0001269) | 3.15082831 |
| 44 | Bilateral microphthalmos (HP:0007633) | 3.06761788 |
| 45 | True hermaphroditism (HP:0010459) | 3.00755509 |
| 46 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.99206484 |
| 47 | Dysdiadochokinesis (HP:0002075) | 2.96165459 |
| 48 | Horizontal nystagmus (HP:0000666) | 2.94340076 |
| 49 | Abnormality of renin-angiotensin system (HP:0000847) | 2.93472257 |
| 50 | Abnormality of glycine metabolism (HP:0010895) | 2.90133332 |
| 51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.90133332 |
| 52 | Late onset (HP:0003584) | 2.88807506 |
| 53 | Neoplasm of the heart (HP:0100544) | 2.86569909 |
| 54 | Tinnitus (HP:0000360) | 2.83511694 |
| 55 | Action tremor (HP:0002345) | 2.82705301 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.82505413 |
| 57 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.81580526 |
| 58 | Dysmetria (HP:0001310) | 2.77046544 |
| 59 | Abnormal social behavior (HP:0012433) | 2.73208961 |
| 60 | Impaired social interactions (HP:0000735) | 2.73208961 |
| 61 | Hepatoblastoma (HP:0002884) | 2.67701187 |
| 62 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.67264238 |
| 63 | Amyotrophic lateral sclerosis (HP:0007354) | 2.62296088 |
| 64 | Hyperactive renin-angiotensin system (HP:0000841) | 2.60131871 |
| 65 | Clumsiness (HP:0002312) | 2.59763143 |
| 66 | Testicular atrophy (HP:0000029) | 2.59380706 |
| 67 | Pigmentary retinal degeneration (HP:0001146) | 2.54273888 |
| 68 | Status epilepticus (HP:0002133) | 2.50974737 |
| 69 | Unilateral renal agenesis (HP:0000122) | 2.47748328 |
| 70 | Abnormality of chloride homeostasis (HP:0011422) | 2.45448378 |
| 71 | Broad-based gait (HP:0002136) | 2.43968757 |
| 72 | Gaze-evoked nystagmus (HP:0000640) | 2.43942117 |
| 73 | Gonadotropin excess (HP:0000837) | 2.42472734 |
| 74 | Male pseudohermaphroditism (HP:0000037) | 2.40717457 |
| 75 | Pancreatic cysts (HP:0001737) | 2.37650600 |
| 76 | Abnormal glucose tolerance (HP:0001952) | 2.37193133 |
| 77 | Preaxial foot polydactyly (HP:0001841) | 2.36467730 |
| 78 | Poor eye contact (HP:0000817) | 2.36132430 |
| 79 | Bicornuate uterus (HP:0000813) | 2.36012252 |
| 80 | Preauricular pit (HP:0004467) | 2.35751521 |
| 81 | Periauricular skin pits (HP:0100277) | 2.35751521 |
| 82 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.35163848 |
| 83 | Decreased circulating renin level (HP:0003351) | 2.32887479 |
| 84 | Hyperkalemia (HP:0002153) | 2.32312084 |
| 85 | Abnormal EKG (HP:0003115) | 2.30715583 |
| 86 | Alkalosis (HP:0001948) | 2.27991787 |
| 87 | Mesangial abnormality (HP:0001966) | 2.26809972 |
| 88 | Abnormality of dentin (HP:0010299) | 2.25244772 |
| 89 | Hemoptysis (HP:0002105) | 2.24045093 |
| 90 | Abnormality of salivation (HP:0100755) | 2.21693313 |
| 91 | Pancreatitis (HP:0001733) | 2.20419586 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 2.20020039 |
| 93 | CNS demyelination (HP:0007305) | 2.19500344 |
| 94 | Postural instability (HP:0002172) | 2.18793127 |
| 95 | Abnormality of dental color (HP:0011073) | 2.18407853 |
| 96 | Hypokalemia (HP:0002900) | 2.16590349 |
| 97 | Atrioventricular block (HP:0001678) | 2.15721996 |
| 98 | Abnormality of the corticospinal tract (HP:0002492) | 2.13483157 |
| 99 | Epileptiform EEG discharges (HP:0011182) | 2.10309335 |
| 100 | Spastic paraplegia (HP:0001258) | 2.09060507 |
| 101 | Increased purine levels (HP:0004368) | 2.08548323 |
| 102 | Hyperuricemia (HP:0002149) | 2.08548323 |
| 103 | Pancreatic fibrosis (HP:0100732) | 2.08479280 |
| 104 | Dysautonomia (HP:0002459) | 2.08133692 |
| 105 | Acne (HP:0001061) | 2.07909672 |
| 106 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.07222984 |
| 107 | Akinesia (HP:0002304) | 2.06370014 |
| 108 | Depression (HP:0000716) | 2.06205570 |
| 109 | Anxiety (HP:0000739) | 2.05333523 |
| 110 | Anorexia (HP:0002039) | 2.04272219 |
| 111 | Resting tremor (HP:0002322) | 2.02012349 |
| 112 | Chronic hepatic failure (HP:0100626) | 2.01790077 |
| 113 | Retinal atrophy (HP:0001105) | 2.01396385 |
| 114 | Glycosuria (HP:0003076) | 2.01015717 |
| 115 | Abnormality of urine glucose concentration (HP:0011016) | 2.01015717 |
| 116 | Bradykinesia (HP:0002067) | 2.00362081 |
| 117 | Heart block (HP:0012722) | 2.00095405 |
| 118 | Amelogenesis imperfecta (HP:0000705) | 1.99872995 |
| 119 | Bradycardia (HP:0001662) | 1.98941303 |
| 120 | Vertigo (HP:0002321) | 1.98698324 |
| 121 | Absent speech (HP:0001344) | 1.98688829 |
| 122 | Subaortic stenosis (HP:0001682) | 1.98653279 |
| 123 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.98653279 |
| 124 | Ragged-red muscle fibers (HP:0003200) | 1.98640801 |
| 125 | Abnormal drinking behavior (HP:0030082) | 1.98401176 |
| 126 | Polydipsia (HP:0001959) | 1.98401176 |
| 127 | Abnormality of potassium homeostasis (HP:0011042) | 1.98316488 |
| 128 | Basal ganglia calcification (HP:0002135) | 1.98253720 |
| 129 | Bundle branch block (HP:0011710) | 1.97334001 |
| 130 | Breast carcinoma (HP:0003002) | 1.96785288 |
| 131 | Encephalitis (HP:0002383) | 1.96666865 |
| 132 | Torticollis (HP:0000473) | 1.95937943 |
| 133 | Truncal ataxia (HP:0002078) | 1.95515905 |
| 134 | Delayed puberty (HP:0000823) | 1.95263029 |
| 135 | Protruding tongue (HP:0010808) | 1.94696797 |
| 136 | Hyperglycinemia (HP:0002154) | 1.94272033 |
| 137 | Microvesicular hepatic steatosis (HP:0001414) | 1.94078039 |
| 138 | Increased circulating renin level (HP:0000848) | 1.91696396 |
| 139 | Pulmonary embolism (HP:0002204) | 1.91617105 |
| 140 | Peripheral demyelination (HP:0011096) | 1.90963108 |
| 141 | Opisthotonus (HP:0002179) | 1.90794324 |
| 142 | Supranuclear gaze palsy (HP:0000605) | 1.90041774 |
| 143 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.88624319 |
| 144 | Adrenal overactivity (HP:0002717) | 1.88619557 |
| 145 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.88521619 |
| 146 | Neurofibrillary tangles (HP:0002185) | 1.87860838 |
| 147 | Abnormality of vitamin B metabolism (HP:0004340) | 1.87604629 |
| 148 | Hyperammonemia (HP:0001987) | 1.87358902 |
| 149 | Prolonged QT interval (HP:0001657) | 1.86905318 |
| 150 | Craniofacial hyperostosis (HP:0004493) | 1.86694900 |
| 151 | Onion bulb formation (HP:0003383) | 1.86352290 |
| 152 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86232751 |
| 153 | Focal segmental glomerulosclerosis (HP:0000097) | 1.85157872 |
| 154 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.83635538 |
| 155 | Sensory axonal neuropathy (HP:0003390) | 1.83424893 |
| 156 | Spastic gait (HP:0002064) | 1.82781843 |
| 157 | Tented upper lip vermilion (HP:0010804) | 1.82200423 |
| 158 | Rapidly progressive (HP:0003678) | 1.82060382 |
| 159 | Fetal akinesia sequence (HP:0001989) | 1.80562621 |
| 160 | Syncope (HP:0001279) | 1.79789361 |
| 161 | Deep palmar crease (HP:0006191) | 1.78950817 |
| 162 | Deeply set eye (HP:0000490) | 1.78561599 |
| 163 | Anal stenosis (HP:0002025) | 1.76571304 |
| 164 | Bifid tongue (HP:0010297) | 1.76162103 |
| 165 | Focal dystonia (HP:0004373) | 1.74731228 |
| 166 | EEG with generalized epileptiform discharges (HP:0011198) | 1.74594159 |
| 167 | Hyperaldosteronism (HP:0000859) | 1.74469007 |
| 168 | Stereotypic behavior (HP:0000733) | 1.72890736 |
| 169 | Abnormal eating behavior (HP:0100738) | 1.71054862 |
| 170 | Incomplete penetrance (HP:0003829) | 1.70706884 |
| 171 | Embryonal renal neoplasm (HP:0011794) | 1.70124940 |
| 172 | Achilles tendon contracture (HP:0001771) | 1.69667060 |
| 173 | Ventricular fibrillation (HP:0001663) | 1.68072608 |
| 174 | Abnormality of binocular vision (HP:0011514) | 1.67810349 |
| 175 | Diplopia (HP:0000651) | 1.67810349 |
| 176 | Abnormality of pain sensation (HP:0010832) | 1.66459940 |
| 177 | Impaired pain sensation (HP:0007328) | 1.66459940 |
| 178 | Craniofacial dystonia (HP:0012179) | 1.66214585 |
| 179 | Ependymoma (HP:0002888) | 1.63775478 |
| 180 | Delusions (HP:0000746) | 1.62883717 |
| 181 | Inability to walk (HP:0002540) | 1.62460963 |
| 182 | Hemiplegia (HP:0002301) | 1.62224922 |
| 183 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.61290605 |
| 184 | Anomalous pulmonary venous return (HP:0010772) | 1.60716565 |
| 185 | Supernumerary nipples (HP:0002558) | 1.60185449 |
| 186 | Ventricular arrhythmia (HP:0004308) | 1.60060091 |
| 187 | Generalized hypotonia (HP:0001290) | 1.59967964 |
| 188 | Generalized myoclonic seizures (HP:0002123) | 1.59341056 |
| 189 | Open mouth (HP:0000194) | 1.57509316 |
| 190 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.56346167 |
| 191 | Skin pits (HP:0100276) | 1.54235719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 9.63308724 |
| 2 | WNK3 | 6.45773889 |
| 3 | EPHA4 | 6.18132190 |
| 4 | NTRK3 | 5.16498083 |
| 5 | TXK | 4.49381805 |
| 6 | PINK1 | 3.27970121 |
| 7 | GRK5 | 3.16124670 |
| 8 | SIK3 | 2.82830978 |
| 9 | ACVR1B | 2.74735225 |
| 10 | BLK | 2.58189279 |
| 11 | EEF2K | 2.49737297 |
| 12 | CDK12 | 2.48043654 |
| 13 | MAP3K9 | 2.43197872 |
| 14 | RIPK4 | 2.39215654 |
| 15 | MAPKAPK3 | 2.27706438 |
| 16 | MAP3K4 | 2.14256915 |
| 17 | SIK2 | 2.13025964 |
| 18 | MAP2K7 | 2.12157680 |
| 19 | YES1 | 2.07790677 |
| 20 | NTRK1 | 2.01753752 |
| 21 | MINK1 | 1.98603563 |
| 22 | CASK | 1.91668611 |
| 23 | CCNB1 | 1.89803510 |
| 24 | GRK7 | 1.89466070 |
| 25 | MAP2K4 | 1.88362982 |
| 26 | NTRK2 | 1.83897734 |
| 27 | GRK6 | 1.74819507 |
| 28 | CAMK2B | 1.66444603 |
| 29 | NEK2 | 1.61314424 |
| 30 | TNIK | 1.57410916 |
| 31 | MAP4K2 | 1.56941771 |
| 32 | FES | 1.50017511 |
| 33 | KSR1 | 1.49107506 |
| 34 | KSR2 | 1.46262163 |
| 35 | PRKCG | 1.45789874 |
| 36 | MAPKAPK5 | 1.43247913 |
| 37 | NME1 | 1.41764155 |
| 38 | LMTK2 | 1.39022467 |
| 39 | MARK1 | 1.36653189 |
| 40 | PLK2 | 1.34000690 |
| 41 | CAMK2A | 1.32277045 |
| 42 | ADRBK2 | 1.30223810 |
| 43 | IRAK1 | 1.30001122 |
| 44 | CDK5 | 1.28512522 |
| 45 | PRKCZ | 1.26089695 |
| 46 | ZAK | 1.24115949 |
| 47 | PIK3CA | 1.20764485 |
| 48 | PAK6 | 1.17162981 |
| 49 | TRPM7 | 1.09084445 |
| 50 | MATK | 1.08155261 |
| 51 | MAPK13 | 1.05961525 |
| 52 | MARK2 | 1.03993376 |
| 53 | BCR | 1.03772556 |
| 54 | PRPF4B | 1.01034700 |
| 55 | CAMK1D | 0.99387449 |
| 56 | TYRO3 | 0.98241551 |
| 57 | MAP3K13 | 0.98116693 |
| 58 | WNK4 | 0.97555328 |
| 59 | GRK1 | 0.96153901 |
| 60 | CSK | 0.93381754 |
| 61 | MAP3K12 | 0.92584083 |
| 62 | PTK2B | 0.92492129 |
| 63 | STK38L | 0.91346007 |
| 64 | CAMK1 | 0.90502470 |
| 65 | CAMK2D | 0.90147604 |
| 66 | LIMK1 | 0.89942835 |
| 67 | STK38 | 0.87680143 |
| 68 | MOS | 0.86730924 |
| 69 | TAOK3 | 0.83029080 |
| 70 | DAPK1 | 0.82746805 |
| 71 | WNK1 | 0.80621549 |
| 72 | BMPR2 | 0.79257453 |
| 73 | UHMK1 | 0.78519334 |
| 74 | STK24 | 0.78080579 |
| 75 | ERN1 | 0.78077063 |
| 76 | AKT3 | 0.76081931 |
| 77 | EIF2AK3 | 0.75614005 |
| 78 | FGR | 0.75109291 |
| 79 | CAMK2G | 0.71525882 |
| 80 | FER | 0.71014098 |
| 81 | MAP3K7 | 0.70686034 |
| 82 | CAMK4 | 0.69566140 |
| 83 | BMPR1B | 0.68381316 |
| 84 | PAK3 | 0.66203531 |
| 85 | CDK18 | 0.65921034 |
| 86 | PRKAA2 | 0.65842691 |
| 87 | DAPK2 | 0.65634492 |
| 88 | PRKCH | 0.64710730 |
| 89 | DYRK1A | 0.60174178 |
| 90 | MET | 0.59380176 |
| 91 | TTK | 0.59187085 |
| 92 | MUSK | 0.59108591 |
| 93 | CDK14 | 0.57229573 |
| 94 | PRKCE | 0.56675518 |
| 95 | ADRBK1 | 0.55916762 |
| 96 | CDK15 | 0.55720319 |
| 97 | MAPK7 | 0.55453740 |
| 98 | MAPK11 | 0.55421029 |
| 99 | MST1R | 0.54925260 |
| 100 | SGK1 | 0.54495570 |
| 101 | PDK1 | 0.54290264 |
| 102 | CSNK1E | 0.54067914 |
| 103 | STK39 | 0.54038608 |
| 104 | CAMKK1 | 0.53712079 |
| 105 | IGF1R | 0.53226894 |
| 106 | PRKD2 | 0.52944876 |
| 107 | MYLK | 0.52663436 |
| 108 | ARAF | 0.51817540 |
| 109 | PNCK | 0.51592711 |
| 110 | TIE1 | 0.51543402 |
| 111 | EIF2AK2 | 0.49959889 |
| 112 | CDK3 | 0.49945205 |
| 113 | PHKG1 | 0.49648359 |
| 114 | PHKG2 | 0.49648359 |
| 115 | CAMKK2 | 0.47929151 |
| 116 | CSF1R | 0.47796007 |
| 117 | RPS6KA3 | 0.47705652 |
| 118 | INSRR | 0.47264781 |
| 119 | PRKACA | 0.47007086 |
| 120 | FYN | 0.46569509 |
| 121 | ERBB2 | 0.45896060 |
| 122 | MAP2K1 | 0.45816625 |
| 123 | PRKACB | 0.45716192 |
| 124 | CDK11A | 0.45091624 |
| 125 | ALK | 0.43989537 |
| 126 | SGK223 | 0.43282030 |
| 127 | SGK494 | 0.43282030 |
| 128 | PRKCA | 0.42757948 |
| 129 | PRKD3 | 0.42637175 |
| 130 | MAP2K6 | 0.42446886 |
| 131 | PRKCB | 0.41794762 |
| 132 | NUAK1 | 0.41593385 |
| 133 | IRAK2 | 0.39852391 |
| 134 | PRKACG | 0.39808852 |
| 135 | MAPK10 | 0.36454506 |
| 136 | CSNK1A1 | 0.36072006 |
| 137 | PRKG2 | 0.35934452 |
| 138 | CHEK2 | 0.35376931 |
| 139 | OXSR1 | 0.34721403 |
| 140 | MAP3K6 | 0.34520491 |
| 141 | BCKDK | 0.34259066 |
| 142 | CAMK1G | 0.34191873 |
| 143 | PRKG1 | 0.33744231 |
| 144 | OBSCN | 0.33361634 |
| 145 | DDR2 | 0.32729624 |
| 146 | SGK2 | 0.32455240 |
| 147 | PKN1 | 0.32338219 |
| 148 | FLT3 | 0.31437583 |
| 149 | NEK6 | 0.31279454 |
| 150 | JAK1 | 0.29194570 |
| 151 | PDPK1 | 0.28667522 |
| 152 | PLK4 | 0.28460317 |
| 153 | RPS6KB2 | 0.27117412 |
| 154 | NEK1 | 0.25730871 |
| 155 | CHUK | 0.19831905 |
| 156 | TEC | 0.18348174 |
| 157 | MST4 | 0.15252549 |
| 158 | GSK3A | 0.14341166 |
| 159 | PRKCQ | 0.14309453 |
| 160 | CDC42BPA | 0.12473979 |
| 161 | INSR | 0.12048166 |
| 162 | TGFBR1 | 0.11885932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 5.15927234 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.45694431 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.26569278 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.32880642 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 3.07853766 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.07356170 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.99548155 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.90969549 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.89324706 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.78495039 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72221904 |
| 12 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.64865681 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.46068850 |
| 14 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.46054291 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.45432579 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 2.41674361 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.39998871 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.28423953 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.26709554 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.23231122 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 2.15734126 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13092069 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 2.02787651 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.00241030 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98103052 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.92670147 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91024335 |
| 28 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.90406769 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82056930 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81879047 |
| 31 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.78564403 |
| 32 | Insulin secretion_Homo sapiens_hsa04911 | 1.75295516 |
| 33 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.74177292 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.72121272 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60855306 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57173590 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.55712283 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.54426437 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51237764 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50615131 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.50136697 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.46680482 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.45837163 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44870384 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.43122591 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 1.42386025 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36524850 |
| 48 | Axon guidance_Homo sapiens_hsa04360 | 1.34549193 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.34340081 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33879161 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33691273 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33367532 |
| 53 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.32665721 |
| 54 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29767857 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27864268 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25588841 |
| 57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.24725516 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23820000 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19788246 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.18064280 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17987070 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17550402 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15765164 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15363218 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.15076877 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.15064462 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13945122 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10568964 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09728857 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09091714 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.08839892 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03589869 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 1.02944492 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01788086 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00851839 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00171769 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98304764 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97594976 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96765309 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93965728 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.92043694 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90427090 |
| 83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.90004985 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85080890 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84719704 |
| 86 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84404620 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83616741 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82570214 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81896248 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81330096 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80475540 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76407472 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76390120 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.74385083 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.71326763 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67287941 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62808497 |
| 98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62486528 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62424305 |
| 100 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61670121 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60886827 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60057535 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56849367 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.56767574 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56555329 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56240172 |
| 107 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55809373 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.55633933 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.55173894 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54553554 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53832965 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53641244 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53615317 |
| 114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52642419 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51282914 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50110892 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48502436 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48153106 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46768330 |
| 120 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45399315 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44562830 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44423534 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42880516 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42825939 |
| 125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41904233 |
| 126 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41722196 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38880688 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38364059 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36838787 |
| 130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36704249 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35984924 |
| 132 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35085299 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34040549 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33544306 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33078033 |
| 136 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33068714 |
| 137 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32921764 |
| 138 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32410234 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31897965 |
| 140 | Phototransduction_Homo sapiens_hsa04744 | 0.30485693 |
| 141 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27546624 |
| 142 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27154136 |
| 143 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26273819 |
| 144 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.26029380 |
| 145 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24693007 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24037386 |
| 147 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22545837 |
| 148 | Circadian rhythm_Homo sapiens_hsa04710 | 0.19489605 |
| 149 | Alcoholism_Homo sapiens_hsa05034 | 0.17615346 |
| 150 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.16054418 |
| 151 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.15662009 |
| 152 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15074860 |
| 153 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14290967 |
| 154 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.13359189 |
| 155 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.13076514 |
| 156 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.12969356 |

